Stay updated with breaking news from Von Hoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The Foundation is excited to hold its first live, in-person weekend event since the pandemic hit. Expect a fun-filled weekend gathering of...
Press release content from Business Wire. The AP news staff was not involved in its creation. NOXXON Appoints Leading Pancreatic Cancer Experts to Scientific Advisory Board February 8, 2021 GMT Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today the appointment of four leading pancreatic cancer experts to its Scientific Advisory Board (SAB). Led by the newly appointed Chair, Dr. Jose Saro, the SAB will provide strategic and scientific counsel to NOXXONт...
Compound derived from thunder god vine could improve outcomes for pancreatic cancer patients The results of a pre-clinical study led by researchers at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest how a compound derived from the thunder god vine -- an herb used in China for centuries to treat joint pain, swelling and fever -- is able to kill cancer cells and potentially improve clinical outcomes for patients with pancreatic cancer. The medicinal plant's key ingredient, triptolide, is the basis of a water-soluble prodrug called Minnelide, which app...
┬аE-Mail PHOENIX, Ariz. -- Dec. 14, 2020 -- The results of a pre-clinical study led by researchers at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest how a compound derived from the thunder god vine -- an herb used in China for centuries to treat joint pain, swelling and fever -- is able to kill cancer cells and potentially improve clinical outcomes for patients with pancreatic cancer. The medicinal plant's key ingredient, triptolide, is the basis of a water-soluble prodrug called Minnelide, which appears to attack pancreatic cancer cells and the c...